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tor p21 is not required by VECs to attain a terminally differenti-The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithe-
ated VEC phenotype. However, the loss of p21, in diseaselial cell proliferation in experimental glomerulonephritis.
states, is associated with VEC re-entry into the cell cycle andBackground. During glomerulogenesis, visceral glomerular
the development of a dedifferentiated proliferative phenotype.epithelial cells (VECs) exit the cell cycle and become terminally
differentiated and quiescent. In contrast to other resident glo-
merular cells, VECs undergo little if any proliferation in re-
sponse to injury. However, the mechanisms for this remain Glomerular endothelial and mesangial cells proliferateunclear. Cell proliferation is controlled by cell-cycle regula-
in many forms of glomerular disease [1]. In contrast, thetory proteins where the cyclin-dependent kinase inhibitor
visceral glomerular epithelial cell (VEC) or podocytep21Cip1,WAF1 (p21) inhibits cell proliferation and is required for
differentiation of many nonrenal cell types. does not readily proliferate in response to injury [2, 3].
Methods. To test the hypothesis that p21 is required to main- Thus, in diseases of the VEC, such as minimal change,
tain a differentiated and quiescent VEC phenotype, experimen- membranous nephropathy, and focal glomerulosclerosis,tal glomerulonephritis was induced in p21 knockout (2/2)
VEC proliferation has not been detected. However, inand p21 wild-type (1/1) mice with antiglomerular antibody.
diseases such as HIV or collapsing glomerulopathy, VECDNA synthesis (proliferating cell nuclear antigen, bromodeox-
yuridine staining), VEC proliferation (multilayers of cells in hypercellularity has been demonstrated [4]. Although
Bowman’s space), matrix accumulation (periodic acid-Schiff, many authorities believe that the lack of VEC prolifera-
silver staining), apoptosis (TUNEL), and renal function (serum tion in vivo is because this cell type is terminally differen-urea nitrogen) were studied on days 5 and 14 (N 5 6 per time
tiated, the determinants of VEC proliferation have notpoint). VECs were identified by location, morphology, ezrin
yet been fully elucidated, and it remains unclear whystaining, and electron microscopy. VEC differentiation was
measured by staining for Wilms’ tumor-1 gene. VECs proliferate in some but not all forms of glomerular
Results. Kidneys from unmanipulated p212/2 mice were injury.
histologically normal and did not have increased DNA synthe- Cell proliferation is controlled at the nuclear level by
sis, suggesting that p21 was not required for the induction of
cell-cycle regulatory proteins [5]. Progression throughVEC terminal differentiation. Proliferating cell nuclear antigen
the cell cycle requires that cyclin-dependent kinasesand bromodeoxyuridine staining was increased 4.3- and 3.3-
(CDKs) be activated by partner cyclins [6, 7]. CDKs arefold, respectively, in p212/2 mice with glomerulonephritis
(P , 0.0001 vs. p211/1 mice). At each time point, VEC prolif- negatively regulated by cyclin-kinase inhibitors (CKIs),
eration was also increased in nephritic p212/2 mice (P , which inhibit cell proliferation by causing cell-cycle ar-
0.0001 vs. p211/1 mice). VEC re-entry into the cell cycle rest [8]. Two families of CKIs have been identified basedwas associated with the loss of Wilms’ tumor-1 gene staining.
on sequence homology and their target cyclin-CDK com-Nephritic p212/2 mice had increased extracellular matrix pro-
plexes that are inhibited [8]. The INK4 family of CKIs,tein accumulation and apoptosis and decreased renal function
(serum urea nitrogen) compared with p211/1 mice (P , p15, p16, p18, p19, inhibit G1 CDKs. The CIP/KIP family
0.001). of CKI, which includes p21CIP1,WAF1 (p21) [9–12], p27Kip1
Conclusion. These results show that the cyclin kinase inhibi- (p27) [13, 14], and p57Kip2 (p57) [15], share homology at
the amino terminus and inhibit G1- and S-phase cyclin-
CDK complexes. Only p21 binds to and inhibits theKey words: glomerulus, podocyte, cell cycle, kidney, p21, cyclin depen-
dent kinase, visceral glomerular epithelial cells, injury. proliferating cell nuclear antigen (PCNA) through its
carboxy terminus [16, 17]. Furthermore, p21 exists inReceived for publication November 6, 1998
quaternary complexes that contain cyclin, CDKs, andand in revised form February 1, 1998
Accepted for publication February 4, 1998 PCNA in normal cells [18]. In contrast to other members
of this family of CKIs, p21 is transcriptionally regulated 1999 by the International Society of Nephrology
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through p53-dependent [11] and p53-independent path- of Health guidelines for the Care and Use of Laboratory
Animals.ways [19].
We have recently shown that p21 expression is in-
Immunostainingcreased in response to immune-mediated injury to the
VECs in the passive Heymann nephritis (PHN) model Immunofluorescence staining. To ensure that the glo-
merular deposition of the sheep antiglomerular antibodyof membranous nephropathy and is associated with an
increase in DNA synthesis but not proliferation [20]. was similar in p212/2 and p211/1 mice, tissues from
normal and diseased mice were embedded in OCT Com-Furthermore, giving the mitogen basic fibroblast growth
factor to PHN rats decreases p21 expression, which is pound (Miles, Elkart, IN, USA) and rapidly snap frozen
in isopentane in liquid nitrogen as previously describedassociated with increased DNA synthesis [20]. In this
study, we tested the postulate that p21 is required to [23]. Four-micrometer-thick frozen sections were stained
with fluorescein isothiocyanate-conjugated antibodies tomaintain a differentiated and quiescent VEC phenotype.
Our results show that glomerular epithelial cell prolifera- sheep IgG and mouse C3 (Cappel, Durham, NC, USA).
To measure the autologous phase of the immune re-tion was greatly increased in p212/2 mice with experi-
mental glomerulonephritis, evidence strongly in favor of sponse, immunostaining was also performed with fluo-
rescein isothiocyanate-conjugated antibodies to mousethis hypothesis, and that this was associated with in-
creased matrix production and decreased renal function. IgG (Cappel). Staining was quantitated on 50 consecu-
tive glomeruli and graded 0 to 41 based on the intensity
of the staining and the percentage of glomerular surface
METHODS
area that stained, as described elsewhere [24]. To deter-
Animal model of experimental glomerulonephritis mine if fibrinogen was increased in this model, staining
was performed with an antibody to mouse fibrinogenExperimental glomerulonephritis was induced in p21
knockout (p212/2) and p21 wild-type (p211/1) mice (Cappel).
Assessment of glomerular cell proliferation. Glomeru-aged 14 , 20 weeks (weight 28 , 38 g) with a sheep
antibody to rabbit glomeruli (0.5 ml/20 g body wt intra- lar cell proliferation was measured by the following
methods. (1) PAS stain. Four-micrometer-thick methylperitoneal injections per day for two consecutive days).
Briefly, rabbit glomeruli for immunization were isolated carnoys fixed sections were stained with periodic acid-
Schiff reagent (PAS) or methenamine-silver to measureby differential sieving techniques and contained less than
one tubular fraction per 100 glomeruli. Sheep antirabbit glomerular cell proliferation, which was classified based
on the number of cell layers in Bowman’s space: (a) mildglomerular antibody was produced in a sheep immunized
three to four times at two-week intervals with lyophilized proliferation was defined as two layers of cells, and (b)
severe proliferation was defined as three or more layerswhole rabbit glomeruli emulsified in complete Freund’s
adjuvant at the first immunization and in incomplete of cells occupying Bowman’s space. To measure the per-
centage of glomeruli with these changes, a minimumFreund’s adjuvant at later immunizations. Antisera were
heat inactivated at 568C for 30 minutes, and immune of 50 glomeruli from each animal were examined. The
percentage of mild and severe proliferation was alsoIgG was isolated by using caprylic acid.
p212/2 and p211/1 mice [21] were sacrificed at day recorded in each animal. (2) PCNA staining (a marker
of DNA synthesis) with a murine monoclonal antibody5 and day 14 (N 5 6 at each time point per group)
after the second injection of antiglomerular antibody. to PCNA (19A2; Coulter Immunology, Hialeah, FL,
USA; immunoperoxidase staining is discussed later inUnmanipulated age-matched p211/1 and p212/2 mice
served as normal controls (N 5 6 in each group). Renal this article). (3) BrdU staining (a marker of DNA synthe-
sis) with a murine monoclonal antibody to BrdU (immu-function was assessed by urine protein excretion and
serum urea nitrogen level. Urine from each animal was noperoxidase staining is also discussed later; Amersham
Life Science).collected for 24 hours prior to sacrifice, and protein ex-
cretion was quantitated by the sulfosalicylic acid method. Identification of proliferating glomerular cell type. The
following methods were used to determine which glo-Blood samples were also obtained at sacrifice for serum
urea nitrogen measurement as previously described [22]. merular cell type underwent DNA synthesis and which
cell type proliferated to make up the multilayers of cellsTo measure DNA synthesis, each animal was injected
with bromodeoxyuridine (BrdU; cell proliferation kit; 1 in Bowman’s space. (a) The first was ezrin staining with
a rabbit polyclonal antibody to ezrin (gift from Heinzml/100 g body wt; Amersham Life Science, Arlington
Heights, IL, USA) intraperitoneally two hours before Furthmayr, Stanford University School of Medicine,
Stanford, CA, USA), which is expressed on visceral andsacrifice. Kidney biopsies were fixed in formalin, methyl
Carnoy’s solution, OCT, and half-strength Karnofskys. parietal glomerular epithelial cells, as previously de-
scribed and utilized [25]. (b) To determine the presenceAll animal studies were performed in an accredited ani-
mal care facility in accord with the National Institutes of infiltrating cells, rat monoclonal antibodies to mouse
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Table 1. Serum urea nitrogen (mg/dl) in normal mice and at daysneutrophils (clone 7/4; Catalag Laboratories, Burlin-
5 and 14 of glomerulonephritis
game, CA, USA), macrophages (F4/80; Catalag), T-lym-
Normal Day 5 Day 14phocyte CD4 and CD8 antigens (immunoperoxidase
p212/2 mice 53.669.6 140.1624.6a 243.869.3a,bstaining on acetone fixed frozen tissue sections; Catalag)
p211/1 mice 53.062.5 153.6613.1a 127.7624.9awere used. Mouse spleen served as a positive control.
Values are mean 6 se.(c) Rabbit polyclonal antibody to Wilms tumor-1 gene
a P , 0.01 vs. normal in each group
(Santa Cruz Biotechnology, Santa Cruz, CA) was a b P 5 0.0012 vs. p211/1 mice at day 14
marker of differentiated VEC [26]. (d) The glomerular
cell type undergoing DNA synthesis was also determined
by double immunostaining for BrdU and ezrin (discussed
later in this article). (e) To ensure that the proliferating tuft area involvement as follows: grade 0 5 normal glo-
cell type was not proximal tubule, immunostaining was merulus; grade 1 5 sclerosis involved less than 25% of
performed with an antibody to rat proximal tubular glomerular tuft area; grade 2 5 sclerosis involving 25 to
brush border (anti-Fx1A) [27]. (f) To define better which 50%; grade 3 5 sclerosis involving 50 to 75%; and grade
glomerular cell type was involved at an ultrastructural 4 5 sclerosis involving 75 to 100% of glomerular tuft
level, tissues were fixed in half-strength Karnofsky’s solu- area. A minimum of 50 glomeruli were evaluated in
tion (1% paraformaldehyde and 1.25% glutaraldehyde individual animals, and the mean score 6 sem was re-
in 0.1 m Na cacodylate buffer, pH 7.0), postfixed in os- ported.
mium tetroxide, dehydrated in graded ethanol, and em- Measuring apoptosis. To measure DNA nicking, a
bedded in epoxy resin, and electron microscopy was per- marker of apoptosis, the TUNEL assay was performed
formed. Thin sections were stained with uranyl acetate on formalin-fixed tissue as previously described [20, 28].
and lead citrate and examined with a Philips 410 (Philips Terminal deoxynucleotidyl transferase (TdT) was omit-
Export BV, Eindhoven, The Netherlands) electron mi- ted from the nucleotide mixture as a negative control.
croscope. Tissue sections treated with DNAse to introduce DNA
Single indirect immunoperoxidase staining. This was breaks in all nuclei were used as positive controls. Quan-
performed on 4 mm sections of methyl Carnoy’s fixed titation of TUNEL staining was performed on more than
kidney tissues as previously described with the primary 50 glomeruli from each animal in a blinded fashion. Re-
antibodies listed earlier here. For BrdU staining, tissue sults were reported as the number of positive TUNEL
sections were boiled in a microwave for 10 minutes in staining cells 6 sem per glomerular cross section.
0.01 m sodium citrate buffer, pH 6.0, and staining was
Statistical analysisperformed according to the manufacturer’s instructions
(Amersham Proliferation Kit; Amersham). For all im- The Mann–Whitney U-test was used for statistical
munostains, primary antibodies were incubated over- analysis. All values were expressed as mean 6 sem. A
night at 48C, followed by a biotinylated secondary anti- P value of less than 0.05 was considered statistically
body incubated for 30 minutes at room temperature and significant.
a horseradish peroxidase-conjugated avidin D at room
temperature for 20 minutes. Brown cytoplasmic staining
RESULTSwas detected with diaminobenzidine (DAB), and black
Baseline p212/2 mice kidneys are normalnuclear staining (PCNA, BrdU) was detected with nickel
as a chromogen. Controls included omitting the primary The phenotype of p212/2 mice used in this study
antibody and substituting the primary antibody with an has been previously reported as normal [21]. Our study
irrelevant antibody of the same IgG class. showed that p212/2 and p211/1 mice not exposed to
Double-immunostaining. Sections were first stained antibody (normal controls) had normal renal function,
for BrdU using nickel as a chromagen, followed by the as measured by serum urea nitrogen (Table 1) and urine
antibody to ezrin, which was detected with the vectastain protein excretion. The renal histology in control p212/2
ABC-AP kit using vector red (Vector Laboratories, and p211/1 mice was normal by light (results not shown)
Burlingame, CA, USA) as a chromagen. and electron microscopy (results not shown). There was
Quantitation of immunostaining for each antibody was also no staining for mouse IgG and C3, indicating that no
performed on more than 50 glomeruli from each animal spontaneous glomerular antibody deposition occurred in
in a blinded fashion. Results were reported as the number these mice.
of positive staining cells per glomerular cross section 6
Antibody deposition was similar in p212/2 andsem.
p211/1 miceAssessment of glomerulosclerosis. Glomerulosclerosis
was measured on silver-stained sections and was graded Glomerular immunofluorescence staining was present
for sheep IgG, mouse IgG, and C3 in all glomeruli inquantitatively based on the percentage of glomerular
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both p211/1 and p212/2 mice at days 5 and 14 of number of cell layers in Bowman’s space into mild (# 2)
and severe ($ 3) (Fig. 2). At day 5, there was no signifi-disease, and there was no quantitative difference at any
time point in staining for these antigens in p212/2 and cant difference in the number of glomeruli with multilay-
ered cell layers in Bowman’s space in p212/2 mice andp211/1 mice (P . 0.05, data not shown). These results
show that both antiglomerular antibody deposition and p211/1 mice (Fig. 2), although there was a trend toward
more severe proliferation in p212/2 mice (21.7 6 2.0the autologous phase immune response were similar in
p211/1 and p212/2 mice. vs. 15.8 6 5.5%, P . 0.05; Fig. 2). In contrast, at day
14, the percentage of glomeruli with multilayered cells
Light microscopy was 2.4-fold higher in p212/2 mice compared with
p211/1 mice (Fig. 2). Furthermore, at day 14 inThe histological patterns of injury in p211/1 mice
and p212/2 mice were similar (Fig. 1 A, B). However, p212/2 mice, the majority of glomeruli with cell prolifer-
ation were classified as severe.the extent and severity of injury were clearly greater
in p212/2 mice by day 14 of injury compared with Tubulointerstitial changes consisted of tubular dila-
tion, intraluminal tubular casts and widening of the inter-p211/1 controls. The glomerular lesion consisted of var-
ying degrees of capillary collapse, with patterns ranging stitial space accompanied by accumulation of interstitial
leukocytes (results not shown). The severity of thesefrom segmental distribution to global involvement of
glomeruli (Fig. 1 A, B). The most severely affected glo- changes closely paralleled the extent of injury manifest
by glomeruli. Arterial vessels were without demonstra-meruli showed complete or near complete loss of identi-
fiable capillary lumina with relative prominence of the ble histological abnormalities in all of the study groups.
mesangial area because of collapsed matrices and cellu-
Electron microscopylar accumulation (Fig. 1E). Numerous preserved capil-
lary loops in severely injured glomeruli contained occlu- Both p212/2 and control mice exhibited striking evi-
dence of thrombotic microangiopathy (TMA), which wassive intensely PAS stained material, that also stained
positive for fibrin (not shown), characteristic of mi- evident by ultrastructural examination at both day 5 and
14 (Fig. 3), but which was evident only to a much lessercrothrombi. Such severely injured glomeruli were wide-
spread in p212/2 mice at day 14 of the injury process degree in histological section. Characteristic features of
TMA included occlusion of glomerular capillaries by(Fig. 1E) and were only occasionally encountered in
either p212/2 or p211/1 mice at day 5 of the injury thrombus, focal entrapment of leukocytes and erythro-
cytes within thrombi, and widespread dissolution of theprocess.
In the most mildly injured glomeruli, seen most often compact mesangial matrix (mesangiolysis) in mesangial
areas adjacent to thrombosed capillaries. In some glo-at day 5 in p212/2 mice, the histological alterations were
limited to vacuolization of both visceral and parietal meruli without overt thrombi, circulating platelets were
also prominent within capillary lumina.epithelial cells (Fig. 1 A, B). Glomeruli with an injury
ranging from mild to severe also showed accumulations Glomerular basement membranes had no identifiable
abnormalities. In glomeruli or segments of glomeruliof swollen cells within the urinary (Bowman’s) space
adjacent to glomerular capillary loops with staining and without thrombi, VECs demonstrated extensive efface-
ment of foot processes (Fig. 3). Specific abnormalitiesstructural appearances similar to both visceral and pari-
etal epithelial cells (Fig. 1 A, B, E). Sometimes these of VEC bodies in these areas were not identified. An
examination of cells within Bowman’s space indicatedcellular accumulations were limited to clusters of as few
as four to five cells adjacent to a capillary within a single the great majority were most consistent with an epithelial
cell phenotype. These cells demonstrated features of fo-histological plane of section; other times they formed
cell clusters of 10 or more cell bodies, at times filling the cally abundant rough endoplasmic reticulum, numerous
mitochondria, occasionally well-developed Golgi appa-urinary space with an appearance indistinguishable from
a cellular crescent (Fig. 1 E, F). ratus, and relative paucity of lysosomes and granules
such as those found in nearby intracapillary leukocytes.Cells in Bowman’s space were classified based on the
c
Fig. 1. Light micrographs of nephritic kidneys at day 5. In both p211/1 (A) and p212/2 (B) mice, there was vacuolization, detachment, and
cyst formation of the visceral glomerular epithelial cells (VECs). PAS-positive material occluded many of the capillary loops, which were associated
with capillary collapse, and this was more extensive in the p212/2 mice (B). (C and D) BrdU staining. BrdU staining was increased at day 5 in
nephritic p212/2 (D) mice compared with nephritic p211/1 (C) mice, and the pattern of BrdU staining was predominantly in a VEC distribution.
(E) PAS stain of nephritic p212/2 at day 14. There was an occlusion of capillaries and a collapse of the glomerular tuft. Layers of cells filled
Bowman’s space, and these were in a typical VEC distribution. (F) Ezrin stain. Layers of cells in p212/2 mice at day 14 stained positive for Ezrin,
a marker of glomerular epithelial cells.
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At day 14 of glomerulonephritis, glomerular immuno-
staining for PCNA was 4.3-fold greater in p212/2 mice
compared with p211/1 mice (P 5 0.0002; Fig. 4A), and
glomerular staining for BrdU was 3.3-fold increased in
p212/2 mice compared with p211/1 mice (P 5 0.001;
Fig. 4B). Thus, DNA synthesis was significantly in-
creased at all time points in p212/2 mice following
immune-mediated glomerular injury compared with
p211/1 mice. At both days 5 and 14, cells staining posi-
tively for PCNA and BrdU (Fig. 1 C, D) were in a typical
VEC distribution. Furthermore, PCNA- and BrdU-posi-
tive cells had the typical morphological appearance of
VECs on light microscopy.
Proliferating cell type is predominantly visceral
glomerular epithelial cells in nephritic p212/2 mice
We used several methods to determine which glomer-
ular cell type(s) was proliferating in this model. In ne-
phritic p211/1 mice, proliferation was confined to both
Fig. 2. Quantitation of glomerular cell proliferation. Glomerular cell visceral and parietal glomerular epithelial cells. In con-
proliferation was measured by the percentage of glomeruli with cell trast, in nephritic p212/2 mice, the overwhelming cell
multilayers, which was classified as mild (,3 layers; h) or severe ($3
type proliferating was VEC, based on the following evi-layers; j). There was no significant difference in the number of multilay-
ered cells at day 5 of glomerulonephritis between p211/1 and p212/2 dence. First, the multilayered cells in the glomeruli had
mice. At day 14, glomerular cell proliferation increased in nephritic the typical morphological appearance and distribution
p212/2 mice compared with controls, where the majority of cell
on PAS staining of VEC (Fig. 1 E, F). Second, electronmultilayers were severe.
microscopy showed that VECs were vacuolated, swollen,
and detached, which is suggestive of VEC injury (Fig.
3). Third, staining for macrophages, neutrophils, and
In the most severely injured glomeruli, there were CD4 and CD8 lymphocytes was not detected in the glo-
numerous areas of complete detachment of VEC foot meruli of p212/2 and p211/1 mice (Table 2), suggesting
processes from the capillary basement membranes in that it was unlikely that these infiltrating cells made up
addition to foci of foot process effacement. Cells within the multilayered cell structures in Bowman’s space.
the urinary space, although focally numerous, had a pre- Fourth, staining for the tubular brush border was limited
dominately epithelial phenotype as described earlier to the proximal tubules and was not detected in glomeru-
here (Fig. 3). Although these cells frequently had closely lar multilayered cell structures (results not shown). Fifth,
opposed cell bodies, discrete cell attachment sites, such although ezrin stains both visceral and parietal epithelial
as zona occludens, were not identified. cells, double immunostaining showed that the vast ma-
jority (more than 95%) of PCNA- and BrdU-positive
DNA synthesis increased in nephritic p212/2 mice cells were also ezrin positive (PCNA1/ezrin1; BrdU1/
DNA synthesis was measured by immunostaining for ezrin1), and staining for ezrin and PAS on serial sections
PCNA and BrdU (Fig. 1 C, D) and was not detected in showed that the majority (more than 95%) of cells in
the glomeruli of normal p212/2 and p211/1 mice prior the multicell layers that stained positive for ezrin had
to being injected with the sheep antirabbit antibody (Fig. the appearance of typical VECs (Fig. 1F). These data
4). Thus, the loss of p21 by itself was not sufficient to show that the predominant cell type undergoing DNA
induce DNA synthesis or increase glomerular cell num- synthesis and proliferation in nephritic p212/2 were
ber under normal physiological conditions. VECs, whereas both visceral and parietal epithelial cells
Glomerular immunostaining for PCNA and BrdU proliferated in nephritic p211/1 mice.
(Fig. 1 C, D) was increased in p211/1 mice at day 5 of
Proliferating visceral glomerular epithelial cells loseglomerulonephritis compared with normal p211/1 mice
Wilms’ tumor-1 gene staining(Fig. 1 C, D, and Fig. 4). However, glomerular immuno-
staining for PCNA was 1.8-fold greater in p212/2 mice Wilms’ tumor-1 gene is expressed constitutively in nor-
at day 5 compared with p211/1 mice (P 5 0.0002; Fig. mal VECs and is a marker of mature differentiated VECs
4A). Similarly, the number of glomerular cells staining [26]. Figure 5 shows that Wilms’ tumor-1 gene (WT-1)
positive for BrdU was 2.3-fold greater in p212/2 mice at immunostaining was detected in normal p212/2 mice
in a typical VEC distribution. However, in nephriticday 5 compared with p211/1 mice (P 5 0.002; Fig. 4B).
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Fig. 3. Electron micrograph of part of a glomerulus from day 14 p212/2 mouse. A capillary loop (C, lower right) is occluded by thrombus and
contains part of a leukocyte with numerous cytoplasmic granules. The adjacent urinary space contains clusters of cells showing few cytoplasmic
granules prominent rough endoplasmic reticulum and numerous mitochondria. Discrete intercellular junctions between these cells cannot be
identified.
p212/2 mice, VEC immunostaining for WT-1 decreased Glomerulosclerosis was increased in nephritic
p212/2 miceat day 5, which coincided with increased DNA synthesis.
Furthermore, WT-1 staining was not detected in glomer- Glomerulosclerosis was quantitated on silver-stained
uli with multilayered cells at day 14 (Fig. 5) in p212/2 sections (Fig. 6 A, B). Silver staining increased at day 5
mice. These results show that proliferating VECs have in both p211/1 and p212/2 mice, but the difference
lost a feature that characterizes their differentiated phe- did not reach statistical difference between mice strains
at this time point (0.20 6 0.04 vs. 0.33 6 0.15, P .notype.
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Fig. 4. Quantitation of DNA synthesis. DNA synthesis was measured by immunostaining for proliferating cell nuclear antigen (PCNA; A) and
bromodeoxyuridine (BrdU; B). PCNA and BrdU staining was not detected in normal control p211/1 (s) and p212/2 (h) mice. DNA synthesis
increased significantly in nephritic p212/2 mice at day 5 and 14 compared with p211/1 mice.
Table 2. Quantitation of glomerular immunostaining for infiltrating cells in normal and nephritic mice showing that infiltrating cells did not
make up the multilayers of cells in Bowman’s space
Normal Day 5 Day 14
p212/2 p211/1 p212/2 p211/1 p212/2 p211/1
Leukocytes 0.15260.033 0.150 60.024 0.108 60.024 0.173 60.041 0.090 60.027 0.083 60.016
Macrophages 0.01360.007 0.007 60.007 0.072 60.020 0.080 60.007 0.160 60.051 0.093 60.019
CD41 T-cells 0.01360.007 0.013 60.007 0.016 60.007 0.013 60.007 0.023 60.013 0.020 60.007
CD81 T-cells 0.01360.013 0.007 60.007 0.020 60.009 0.013 60.007 0.017 60.008 0.020 60.005
Values are expressed as mean number of cells 6 SE per glomerular cross section.
0.05). In contrast, at day 14, the glomerulosclerosis score Renal function was decreased in p212/2 mice
with glomerulonephritiswas 1.7-fold increased in p212/2 mice compared with
p211/1 (1.29 6 0.13 vs. 0.74 6 0.10, P 5 0.0009). Serum urea nitrogen increased in both p212/2 and
p211/1 mice at day 5 and 14 of glomerulonephritis (Ta-
Glomerular apoptosis was increased in nephritic ble 1), but was higher by a factor of two in p212/2 mice
p212/2 mice compared with p211/1. Urine protein excretion was not
increased at day 14 (16.2 6 2.5 vs. 17.2 6 3.6 mg/24 hr,Apoptosis was measured by TUNEL immunostaining
P . 0.05) in either group.(Fig. 6 C, D, and Fig. 7). Glomerular TUNEL staining
was not detected in normal p212/2 and p211/1 mice
(Fig. 7). Although there was a slight increase in TUNEL DISCUSSION
staining at day 5 of glomerulonephritis in p212/2 and In this study, we show that VEC DNA synthesis and
p211/1 mice compared with normal, TUNEL staining proliferation leading to multilayers of VECs in Bow-
was not different between the two groups (Fig. 7). In man’s space, sometimes resembling crescents in appear-
contrast, TUNEL staining was 3.8-fold greater in ance, are increased in p212/2 mice with experimental
p212/2 mice at day 14 compared with p211/1 mice immune-mediated glomerulonephritis. We demonstrate
(1.11 6 0.08 vs. 0.29 6 0.79 per glomerular tuft area, that this VEC proliferation was associated with increased
glomerulosclerosis and decreased renal function.P , 0.0001; Fig. 6 C, D and Fig. 7).
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Fig. 5. Indirect immunoperoxidase immunostaining for Wilms’ tumor-1 gene (WT-1) in p212/2 mice. (A) Glomerular cells stain positive for
WT-1 in normal p212/2 mice, and this is in a visceral glomerular epithelial cell distribution (arrows). (B) WT-1 staining was not detected in
glomerular cell multilayers in p212/2 mice with glomerulonephritis at day 14.
The cyclin kinase inhibitor p21 is complexed with coincides with VEC exit from the cell cycle and the
acquisition of a terminally differentiated phenotype [39].cyclins, CDKs, and PCNA in normal cells in vitro [18,
29]. There are several lines of evidence to show that p21 The data in this study suggest that p21 is not required
for VEC exit from the cell cycle and the induction oflimits proliferation in vitro and in vivo. Forced overex-
pression of p21 inhibits G1/S transition and arrests the VEC terminal differentiation during glomerulogenesis
and that the loss of p21 by itself was not sufficient tocell cycle in renal [30] and nonrenal cells [11]. Prolifera-
tion is increased in fibroblasts when cellular p21 levels increase glomerular cell proliferation. Thus, p21 is not
essential for normal glomerular development.are lowered with antisense oligonucleotides [31], and the
response to mitogens is increased in keratinocytes from In this study, we showed that staining for PCNA and
BrdU, markers of DNA synthesis, increased in p212/2p212/2 mice in vitro [32]. In addition, a role for p21 has
also been demonstrated in nonrenal cell differentiation mice with glomerulonephritis compared with p211/1
mice. Moreover, the increased VEC number was associ-where p21 expression is induced during embryogenesis
and correlates with cell cycle arrest [33]. The correlation ated with the formation of multilayered structures, some-
times resembling glomerular crescents. Thus, a secondof terminal differentiation with p21 induction has also
been demonstrated in vitro [34–36]. major finding in this study was that following immune-
mediated injury, VECs re-engage the cell cycle and un-Visceral glomerular epithelial cells proliferate during
the S phase of glomerulogenesis and exit the cell cycle dergo marked DNA synthesis and proliferation in the
absence of the cyclin kinase inhibitor p21. The increaseduring the capillary loop phase, where they acquire a
highly specialized, quiescent, and terminally differenti- in VEC number indicates that these cells do not exhibit
a block in cytokinesis, which is a mechanism that hasated cell type [37]. In accord with other organs studied
in these mice [32, 38], the first finding in this study was been proposed to underlie the inability of VECs to prolif-
erate [40]. In the PHN model of immune-mediated VECthat the kidneys of p212/2 mice were normal and that
glomerular DNA synthesis and cell number were not injury, there is a de novo expression of p21 in VECs,
and p21 was complexed to and inhibited the activity ofincreased under normal physiological conditions. In con-
trast, the loss of p57 is associated with abnormal VEC cyclin A-CDK2 [20]. This was accompanied by only low-
grade DNA synthesis of VECs. Interestingly, injectingdevelopment, and VECs from p57 null mice are born
with a fused foot process [15]. In human development, the mitogen basic fibroblast growth factor to PHN rats
decreased p21, but not p27 expression, and this was ac-there is a de novo expression of p27 in VECs, and this
Kim et al: Cell cycle proteins and podocyte proliferation2358
Fig. 6. Silver staining. There was an increase in silver staining at day 14 in nephritic p212/2 mice (B) compared with p211/1 mice (A). (C and
D) TUNEL staining. TUNEL staining, a marker of apoptosis, was increased at day 14 in nephritic p212/2 mice (D) compared with p211/1
mice (C).
companied by increased DNA synthesis [20]. In this with a dedifferentiated VEC phenotype, which can
readily proliferate in response to injury.study, we also showed that DNA synthesis and prolifera-
tion of VECs were associated with the loss of WT-1 By light microscopy, proliferating VECs in this study
often formed two or more layers of cells in Bowman’sstaining, a marker of differentiated VECs. Taken to-
gether, these data suggest that p21 is required to maintain space, sometimes resembling glomerular crescents. In-
deed, some have defined crescents as consisting of twothe terminally differentiated VEC phenotype and sup-
port the idea that in disease, the loss of p21 is associated or more layers of cells, and most studies of the mecha-
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Thus, we believe that this phenomenon we are describing
is a new type of glomerular response to injury represent-
ing marked proliferation of visceral VECs facilitated by
the absence of p21. Although perhaps less relevant to
crescentic glomerulonephritis, it exhibits features seen
in the glomerular lesions described in collapsing glomer-
ulopathy and HIV nephropathy [45, 46]. In addition to
the possible relevance of these findings to human glomer-
ular lesions, the observations reported are clearly central
to understanding the spectrum of responses of the VEC
injury and the factors that modulate them.
The mechanisms underlying VEC proliferation were
not examined in this study. There are no reports of anti-
body alone directly causing glomerular cell proliferation,
and this model is complement independent. Growth fac-
tors may have been increased or released following glo-
merular cell injury in this model. Our data do not support
a direct role of infiltrating cells in this process.
Studies have shown that the cyclin kinase inhibitor
p21 also has different roles in apoptosis in specific cell
lineages. Thus, p21 is not required for apoptosis in cer-
tain nonrenal cells [47], but protects myocytes from
Fig. 7. Quantitation of TUNEL staining. There was a statistically sig- apoptosis [48]. In this study, we showed that apoptosisnificant increase in TUNEL staining in p212/2 mice (h) at day 14
was not detected in normal p212/2 kidneys and was notcompared with controls (p211/1; s).
increased in p212/2 mice at day 5 of glomerulonephritis.
There was a small but significant increase in apoptosis at
day 14 of glomerulonephritis in p212/2 mice compared
nisms of crescent formation have been done in rodent with p211/1 mice. These results differ, therefore, from
nephrotoxic nephritis models such as this one [reviewed the marked increase in apoptosis in tubular epithelial
in 41]. However, current evidence suggests that crescents cells following nonimmune mediated tubulotoxic injury
are composed predominantly of proliferating parietal [49] and suggest that the role for p21 in apoptosis in vivo
VECs, macrophages, and fibroblasts, the latter two cells may be cell-type or injury-type specific. In this study, we
entering Bowman’s space through disruptions in the glo- did not examine heterozygotes p211/2 mice, and one
merular basement membrane and Bowman’s capsule can only speculate that there may have been a gene
[42]. Moreover, the mechanisms that underlie crescent “dose response” and that the injury would be milder
formation involve cell-mediated rather than humoral im- than p212/2 mice. Our findings indicate that the in-
munity and lead to classic features of a delayed hypersen- creased VEC number observed in this model was not
sitivity reaction, including macrophage infiltration, T-cell due to a decrease in the rate of cell removal by apoptosis.
localization, and fibrin deposition [41, 42]. In our study, The results in this study also show that specific cyclin
the development of cell multilayers in Bowman’s space kinase inhibitors modulate the glomerular response
was not associated with identifiable T cells, macrophages to injury differently. Thus, in contrast to p212/2
and fibrin deposits that may be due to the absence of gaps mice, nephritic p272/2 mice have a marked increase in
in the glomerular basement membrane or Bowman’s apoptosis that was in excess of the increase in prolifer-
capsule by light or electron microscopy, as has been ation [22].
shown previously [43, 44]. In this study, we did not mea- In summary, this study shows that p21 is not required
sure differences in the balance between Th1 and Th2 for normal glomerular development and VEC differenti-
responses in p212/2 and p211/1 mice. ation. However, p21 is required to maintain mature
Although available markers do not permit the identity VECs in a differentiated phenotype. Following immune
of the proliferating cells as parietal or visceral VECs in injury, the loss of p21 is associated with re-engagement
this experimental model to be established with certainty, of the cell cycle by VECs and the development of marked
their localization and morphology in nephritic p212/2 proliferation and glomerulosclerosis.
mice strongly suggest they are primarily visceral rather
than parietal VEC associated with crescents. In contrast, ACKNOWLEDGMENTS
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